Upwork to Report Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026 GlobeNewswire January 20, 2026 PALO ALTO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world's human and AI-powered work marketplace, today announced that it will report its financial results for the fourth quarter and full year […]

Toronto, Ontario–(Newsfile Corp. – January 20, 2026) – LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (“LevelJump” or the “Company”), a leading provider of teleradiology and diagnostic imaging services, today announced that it has entered into a cooperation agreement (the “Agreement”) with Frank Teti. Under the terms of the Agreement, LevelJump has agreed to a

NVIDIA AIâ?’Powered, Blockchainâ?’Native Trading Platform Designed to Bridge Traditional Finance and Crypto at Global Scale TOKYO, JAPAN / ACCESS Newswire / January 20, 2026 / Earlyworks Co., Ltd. (NASDAQ:PDC) today announced the successful completion of its acquisition of Perpetual Markets Ltd. Accordingly, the company has rebranded as Perpetuals.com Ltd and its Nasdaq ticker symbol has

Delivered FY25 diluted earnings per share of $10.20 up 8% year-over-year; adjusted diluted earnings per share1 of $10.62 up year-over-year and expects to be the only U.S. airline to grow adjusted EPS1 for FY25 Q4 diluted earnings per share of $3.19; adjusted diluted earnings per share1 of $3.10 — within initial guidance range of $3.00

MELVILLE, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) — Canon U.S.A. Inc., a leader in digital imaging solutions, today announced that its parent company, Canon Inc., ranked seventh in the number of patents granted by the United States Patent and Trademark Office (USPTO) in 2025, placing it in the world's top 10, according to IFI CLAIMS

(AUST:AVR.AX),(NasdaqGM:AVR), MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company“) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that it is offering to sell, subject to market and other

(NasdaqGM:CRVS), SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common

(NASDAQ:BIOA), EMERYVILLE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced a proposed underwritten public offering in which it intends to offer and sell, subject to market and other

(NASDAQ:ERAS), SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock

Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic GlobeNewswire January 20, 2026 MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company“) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing